Back to
Bank of New York Mellon Corp
FPRX8 quarters
Position history for
Bank of New York Mellon Corp's holdings in FIVE PRIME THERAPEUTICS INC
As of its Q1 2021 13F, Bank of New York Mellon held 187,963 shares of FPRX (Five Prime Therapeutics), worth $7.1M. Bank of New York Mellon's 13F filings listed FPRX from Q3 2019 to Q1 2021, 7 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$612,000
Total Shares Change
-157,945
Quarter-by-Quarter History
Other major holders of FPRX: Magnetar Financial LLC, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, RTW INVESTMENTS, LP